ACKR4 restrains antitumor immunity by regulating CCL21

Carly E Whyte1, Maleika Osman1, Ervin E Kara1

  • 1Chemokine Biology Laboratory, Department of Molecular and Biomedical Science, School of Biological Sciences, The University of Adelaide, Adelaide, South Australia, Australia.

Insights

Host atypical chemokine receptor 4 (ACKR4) limits anti-tumor CD8+ T cells in the tumor microenvironment. Blocking ACKR4 increases T cells, inhibits tumor growth, and may improve immunotherapy effectiveness.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Current immunotherapies show promise but face limitations in solid tumors due to low tumor-specific T cell presence.
  • The tumor microenvironment (TME) plays a critical role in regulating anti-tumor immune responses.
  • Understanding factors controlling T cell infiltration and activation in the TME is crucial for enhancing cancer treatments.

Purpose of the Study:

  • To investigate the role of atypical chemokine receptor 4 (ACKR4) in regulating intratumor T cell responses.
  • To determine the impact of ACKR4 on CD8+ T cell accumulation and activation within the tumor microenvironment.
  • To explore ACKR4 and CCL21 as potential therapeutic targets for improving cancer immunotherapy.

Main Methods:

  • Utilized mouse models to study the effects of ACKR4 deficiency on tumor growth and T cell infiltration.
  • Analyzed the expression and function of ACKR4 in nonhematopoietic cells within the TME.
  • Investigated the regulatory mechanisms of ACKR4 on dendritic cell retention and chemokine levels (CCL21) in tumors.

Main Results:

  • Absence of ACKR4 led to increased intratumor CD8+ T cells, which inhibited tumor growth.
  • Nonhematopoietic ACKR4 expression was essential for controlling T cell accumulation.
  • ACKR4 was found to inhibit CD103+ dendritic cell retention by regulating intratumor CCL21 levels.

Conclusions:

  • Host ACKR4 acts as a critical regulator limiting CD8+ T cell accumulation and activation in the tumor microenvironment.
  • ACKR4-mediated regulation of CCL21 influences dendritic cell retention and T cell infiltration.
  • Targeting ACKR4 and CCL21 presents a promising strategy to enhance the efficacy of immunotherapies like immune checkpoint blockade.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K